Ann Neurol

1. FADDA G, Yea C, O'Mahony J, Waters P, et al
   Epstein-Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein-Antibody-Associated Disease.
   Ann Neurol. 2024 Feb 27. doi: 10.1002/ana.26890.
   

   >> Share

   
   

   
   J Neuroimmunol

2. SERAFINI B, Benincasa L, Rosicarelli B, Aloisi F, et al
   EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance.
   J Neuroimmunol. 2024;389:578314.
   

   >> Share

   
   
3. FRID K, Usmann A, Markovits-Pachter T, Binyamin O, et al
   Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis.
   J Neuroimmunol. 2024;389:578313.
   

   >> Share

   
   

   
   J Neurol

4. SCHERER L, Soudant M, Pittion-Vouyovitch S, Debouverie M, et al
   Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.
   J Neurol. 2024 Feb 29. doi: 10.1007/s00415-024-12266.
   

   >> Share

   
   
5. TOLJAN K, Briggs FBS
   Male sexual and reproductive health in multiple sclerosis: a scoping review.
   J Neurol. 2024 Feb 28. doi: 10.1007/s00415-024-12250.
   

   >> Share

   
   
6. LEAVITT VM, Tozlu C, Nelson KE, Boehme AK, et al
   A randomized controlled trial of oral antipyretic treatment to reduce overheating during exercise in adults with multiple sclerosis.
   J Neurol. 2024 Feb 28. doi: 10.1007/s00415-023-12147.
   

   >> Share

   
   
7. VAN DAM M, Krijnen EA, Nauta IM, Fuchs TA, et al
   Identifying and understanding cognitive profiles in multiple sclerosis: a role for visuospatial memory functioning.
   J Neurol. 2024 Feb 26. doi: 10.1007/s00415-024-12227.
   

   >> Share

   
   

   
   Mult Scler

8. GIULIANI G, Zilli C, Caramia F, Di Piero V, et al
   SUNCT syndrome secondary to multiple sclerosis: Not only trigeminal neuralgia.
   Mult Scler. 2024 Mar 1:13524585241235535. doi: 10.1177/13524585241235535.
   

   >> Share

   
   
9. AFZAL RM, Romme Christensen J, Gynthersen RMM, Lebech AM, et al
   Neoehrlichiosis associated with ocrelizumab in a patient with multiple sclerosis: A case report.
   Mult Scler. 2024 Feb 29:13524585241235542. doi: 10.1177/13524585241235542.
   

   >> Share

   
   
10. KARI S, Bucciarelli F, Angles T, Oster AC, et al
    Increased levels of circulating soluble CD226 in multiple sclerosis.
    Mult Scler. 2024 Feb 29:13524585241234489. doi: 10.1177/13524585241234489.
    

    >> Share

    
    
11. HEESEN C, Luhmann D
    Reply: Mobile health interventions in multiple sclerosis: A systematic review.
    Mult Scler. 2024 Feb 29:13524585241234777. doi: 10.1177/13524585241234777.
    

    >> Share

    
    
12. LIM TRU, Kumaran SP, Suthiphosuwan S, Espiritu AI, et al
    Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis.
    Mult Scler. 2024 Feb 28:13524585241228426. doi: 10.1177/13524585241228426.
    

    >> Share

    
    
13. NAKKEN O, Aarseth JH, Wergeland S, Stigum H, et al
    BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.
    Mult Scler. 2024 Feb 27:13524585241230440. doi: 10.1177/13524585241230440.
    

    >> Share

    
    
14. MILLER AE
    Dissemination in time as a requirement for diagnosis of multiple sclerosis: Time for a change?
    Mult Scler. 2024 Feb 27:13524585241233999. doi: 10.1177/13524585241233999.
    

    >> Share

    
    
15. KRIEGER SC, Sinks S, Huang F, Steverson J, et al
    The impact of social distancing measures on anti-JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis.
    Mult Scler. 2024 Feb 26:13524585241232274. doi: 10.1177/13524585241232274.
    

    >> Share

    
    

    
    Neurology

16. 
    Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e209252.
    

    >> Share

    
    
17. BOURDETTE D, Wooliscroft L
    The Challenges of Treating Late-Onset Multiple Sclerosis.
    Neurology. 2024;102:e209146.
    

    >> Share

    
    
18. MOURESAN EF, Mentesidou E, Berglund A, Mckay KA, et al
    Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
    Neurology. 2024;102:e208051.
    

    >> Share

    
    
19. LEMMENS CMC, van Amerongen S, Strijbis EM, Killestein J, et al
    Outcome Reporting Bias in Clinical Trials Researching Disease-Modifying Therapy in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e208032.
    

    >> Share

    
    
20. MARRIE RA, Salter A
    Off-Road Testing: Outcome Reporting Bias in Multiple Sclerosis Trials.
    Neurology. 2024;102:e208099.
    

    >> Share

    
    

    
    Rev Neurol (Paris)

21. PIERRET C, Mainguy M, Leray E
    Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance database.
    Rev Neurol (Paris). 2024 Feb 28:S0035-3787(24)00369.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share